Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients
© 2022 Tas SK et al..
Background: Various variants of the miR-219-1 gene are one of the first genes associated with NSCLC prognosis in the literature.
Objectives: We aimed to genotype two different variants of the miR-219-1 gene and to investigate to using of the result as a biomarker in the diagnosis and treatment of NSCLC.
Materials and Methods: The patients were chosen according to International NSCLC criteria and genomic DNA was isolated from blood (138 patients and 100 healthy individuals). Then qRT-PCR was applied to determine the rs213210 and rs421446 variants of miR-219-1 gene polymorphisms. Allele and genotype frequencies were compared using Pearson's chi-square and Fisher's exact tests test.
Results: We found that TT genotype (p=0,381) in rs213210 compared with CC genotype (p=0,165) and CC genotype (p=0,823) in rs421446 compared with TT genotype (p=0,537) did not show a significantly increased risk of NSCLC. There is no relationship between polymorphisms in miR-219-1 and the outcome of NSCLC.
Conclusion: miRNA single nucleotide polymorphisms can be used as genetic biomarkers to predict cancer susceptibility, early diagnosis, and prognosis. Our study has shown that two variants of miR-219-1 were not related to NSCLC in the Turkish population. The reason for this can be differences in ethnicity, regions, and background of population and these differences could lead to various outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
African health sciences - 22(2022), 4 vom: 11. Dez., Seite 37-45 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tas, Sevgi Kalkanli [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 25.04.2023 Date Revised 25.04.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4314/ahs.v22i4.6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355958198 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355958198 | ||
| 003 | DE-627 | ||
| 005 | 20231226065439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4314/ahs.v22i4.6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1186.xml |
| 035 | |a (DE-627)NLM355958198 | ||
| 035 | |a (NLM)37092101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tas, Sevgi Kalkanli |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.04.2023 | ||
| 500 | |a Date Revised 25.04.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Tas SK et al. | ||
| 520 | |a Background: Various variants of the miR-219-1 gene are one of the first genes associated with NSCLC prognosis in the literature | ||
| 520 | |a Objectives: We aimed to genotype two different variants of the miR-219-1 gene and to investigate to using of the result as a biomarker in the diagnosis and treatment of NSCLC | ||
| 520 | |a Materials and Methods: The patients were chosen according to International NSCLC criteria and genomic DNA was isolated from blood (138 patients and 100 healthy individuals). Then qRT-PCR was applied to determine the rs213210 and rs421446 variants of miR-219-1 gene polymorphisms. Allele and genotype frequencies were compared using Pearson's chi-square and Fisher's exact tests test | ||
| 520 | |a Results: We found that TT genotype (p=0,381) in rs213210 compared with CC genotype (p=0,165) and CC genotype (p=0,823) in rs421446 compared with TT genotype (p=0,537) did not show a significantly increased risk of NSCLC. There is no relationship between polymorphisms in miR-219-1 and the outcome of NSCLC | ||
| 520 | |a Conclusion: miRNA single nucleotide polymorphisms can be used as genetic biomarkers to predict cancer susceptibility, early diagnosis, and prognosis. Our study has shown that two variants of miR-219-1 were not related to NSCLC in the Turkish population. The reason for this can be differences in ethnicity, regions, and background of population and these differences could lead to various outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NSCLC | |
| 650 | 4 | |a miR-219-1 gene | |
| 650 | 4 | |a single-nucleotide polymorphisms | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a MIRN219 microRNA, human |2 NLM | |
| 700 | 1 | |a Coskunpinar, Ender |e verfasserin |4 aut | |
| 700 | 1 | |a Yildiz, Pinar |e verfasserin |4 aut | |
| 700 | 1 | |a Bayraktaroğlu, Mesut |e verfasserin |4 aut | |
| 700 | 1 | |a Kose, Tuba |e verfasserin |4 aut | |
| 700 | 1 | |a Altunkanat, Derya |e verfasserin |4 aut | |
| 700 | 1 | |a Kirkik, Duygu |e verfasserin |4 aut | |
| 700 | 1 | |a Tukenmez, Mustafa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t African health sciences |d 2001 |g 22(2022), 4 vom: 11. Dez., Seite 37-45 |w (DE-627)NLM125540906 |x 1729-0503 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:4 |g day:11 |g month:12 |g pages:37-45 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4314/ahs.v22i4.6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 4 |b 11 |c 12 |h 37-45 | ||